跳转至内容
Merck
CN
  • Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage.

Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage.

Molecular cancer (2015-03-10)
Anne Olazabal-Herrero, Iraia García-Santisteban, Jose Antonio Rodríguez
摘要

In complex with its cofactor UAF1, the USP1 deubiquitinase plays an important role in cellular processes related to cancer, including the response to DNA damage. The USP1/UAF1 complex is emerging as a novel target in cancer therapy, but several aspects of its function and regulation remain to be further clarified. These include the role of the serine 313 phosphorylation site, the relative contribution of different USP1 sequence motifs to UAF1 binding, and the potential effect of cancer-associated mutations on USP1 regulation by autocleavage. We have generated a large set of USP1 structural variants, including a catalytically inactive form (C90S), non-phosphorylatable (S313A) and phosphomimetic (S313D) mutants, deletion mutants lacking potential UAF1 binding sites, a mutant (GG/AA) unable to undergo autocleavage at the well-characterized G670/G671 diglycine motif, and four USP1 mutants identified in tumor samples that cluster around this cleavage site (G667A, L669P, K673T and A676T). Using cell-based assays, we have determined the ability of these mutants to bind UAF1, to reverse DNA damage-induced monoubiquitination of PCNA, and to undergo autocleavage. A non-phosphorylatable S313A mutant of USP1 retained the ability to bind UAF1 and to reverse PCNA ubiquitination in cell-based assays. Regardless of the presence of a phosphomimetic S313D mutation, deletion of USP1 fragment 420-520 disrupted UAF1 binding, as determined using a nuclear relocation assay. The UAF1 binding site in a second UAF1-interacting DUB, USP46, was mapped to a region homologous to USP1(420-520). Regarding USP1 autocleavage, co-expression of the C90S and GG/AA mutants did not result in cleavage, while the cancer-associated mutation L669P was found to reduce cleavage efficiency. USP1 phosphorylation at S313 is not critical for PCNA deubiquitination, neither for binding to UAF1 in a cellular environment. In this context, USP1 amino acid motif 420-520 is necessary and sufficient for UAF1 binding. This motif, and a homologous amino acid segment that mediates USP46 binding to UAF1, map to the Fingers sub-domain of these DUBs. On the other hand, our results support the view that USP1 autocleavage may occur in cis, and can be altered by a cancer-associated mutation.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
甲醛 溶液, Molecular Biology, 36.5-38% in H2O
Sigma-Aldrich
甲醛 溶液, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
SAFC
甲醛 溶液, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
N -乙基马来酰亚胺, purum p.a., ≥99.0% (HPLC)
Roche
X-tremeGENE 9 DNA Transfection Reagent, Polymer reagent for transfecting common cell lines
Sigma-Aldrich
甲醛 溶液, Molecular Biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
羟基脲, 98%, powder
Sigma-Aldrich
正钒酸钠, ≥90% (titration)
Sigma-Aldrich
N -乙基马来酰亚胺, crystalline, ≥98% (HPLC)
Sigma-Aldrich
N -乙基马来酰亚胺, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
正钒酸钠, 99.98% trace metals basis
Sigma-Aldrich
甲醛 溶液, meets analytical specification of USP, ≥34.5 wt. %
Supelco
甲醛 溶液, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
甲醛 溶液, tested according to Ph. Eur.
Sigma-Aldrich
N -乙基马来酰亚胺, BioXtra, ≥98% (HPLC)
Sigma-Aldrich
甲醛-12C 溶液, 20% in H2O, 99.9 atom % 12C
羟基脲, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
羟基脲, Vetec, reagent grade, ≥98%